TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Life Sciences

    Talking Biotech with Dr. Kevin Folta

    Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.

    Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.

    Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

    Advertise

    Copyright: © 2023 Colabra

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Dr. Arvinda Nath: Endogenous Retroviruses and Disease Mar 19, 2022
    Show notes

    Upon sequencing the human genome, scientists were surprised to find that it is composed of about 8% viral sequence. These fossils are relics of ancient primate infections where retroviruses incorporated into the chromosome and became part of the human lineage. While these viral elements have contributed positively to speciation and development of specific human traits, they also have the capacity to become pathogenic. Dr. Advinda Nath is the Clinical Director of the National Institute of Neurological Disorders and Stroke. He joins Talking Biotech to share his experiences, knowledge and predictions in this exciting, emerging area of research.


    Melanie Trecek-King: Evaluating Scientific Claims Mar 12, 2022
    Show notes

    We are bombarded with information, but do we know what sources to trust and how to evaluate specific claims? Melanie Tercek-King joins the podcast to discuss some fundamentals of critical thinking, and implement her tool kit to evaluate which claims have merit, and which might be best disregarded.


    Dr. Robert Paarlberg: Resetting the Table Mar 05, 2022
    Show notes

    In his new book Dr. Robert Paarlberg describes the current state of the food system, focusing on issues like industrial farming, organic farming, restaurants, biotechnology, and how technology will impact farming in the future. In today's podcast we discuss some of the critical points of the book and what food and farming may look like in the future.


    Dr. Monika Gulia-Nuss: Biotech and Tick Vectored Disease Feb 26, 2022
    Show notes

    Ticks are significant disease vectors, with an emerging scope of pathologies associated with tick bites. New technologies have accelerated the ability to genetically engineer ticks, creating new opportunities to understand gene function in ticks, as well as potentially use gene editing to control numbers or affect disease vectoring. Dr. Monika Gulia-Nuss (University of Nevada, Reno) and Dr. Jason Rasgon (Penn State University) describe tick disease transmission, new transformation technology, and potential applications.


    Dr. Anne Simon: Plant Viruses / X Files Science Feb 19, 2022
    Show notes

    Dr. Anne Simon is an expert in plant viruses. She describes some of the current threats to plant biology, and discusses ways that viruses may be used to work for us, rather than against us. She also discusses her time as a technical advisor to The X Files series, and how that experience helped her to share science.

    Follow Dr. Simon on Twitter here!


    Jesus Martin-Garcia: New Therapies for HERV-Based Disease Feb 13, 2022
    Show notes

    Human Endogenous Retroviruses (HERVs) comprise 8% of the human genome and are relics of ancient infections, some dating back to pre-human primates. These resident viral elements can be awakened by viral infections, and have been shown to be tightly associated with diseases like Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS). New data suggest a role for HERVs in the neurological symptoms of long COVID. Today's podcast features a conversation with Jesus Martin-Garcia, CEO and Co-Founder of GeNeuro. New therapies target the rogue proteins arising from these ancient viruses, and show promise in treating, if not reversing, disease progression.

    Follow GeNeuro on Twitter
    GeNeuro Website http://www.geneuro.com/
    YouTube Videos of their technology

    # COLABRA
    Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

    # TALKING BIOTECH
    Twitter: https://twitter.com/talkingbiotech
    Website: https://www.colabra.app/podcasts/talking-biotech/
    Instagram: https://www.instagram.com/colabrahq

    The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.


    Talking Biotech Podcast Changes and Future Feb 13, 2022
    Show notes

    As we enter our eighth year, the podcast is partnering with Colabra, experts in laboratory IT that will help and accelerate your R&D. You won't see changes in content, but you'll see improvements in website, podcast quality, transcripts and other improvements for the listener. I'm grateful for such substantial listenership and the opportunity to have this forum for my passion of sharing science.

    # COLABRA
    Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

    # TALKING BIOTECH
    Twitter: https://twitter.com/talkingbiotech
    Website: https://www.colabra.app/podcasts/talking-biotech/
    Instagram: https://www.instagram.com/colabrahq

    The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.


    Eric Focht: Avocado Genetics and Improvement Feb 05, 2022
    Show notes

    Avocado consumption is rapidly increasing, and global production booming. However, the diversity of fruit choices is typically constrained to Hass. There is tremendous diversity in avocado, featuring a range of flavors, oil content and seasonal availability. In this week’s podcast we speak with Eric Focht who has been running the breeding program at University of California in Riverside. We discuss the genetic origins, the breeding priorities, and next steps in the genetic improvement of the crop.

    # COLABRA
    Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

    # TALKING BIOTECH
    Twitter: https://twitter.com/talkingbiotech
    Website: https://www.colabra.app/podcasts/talking-biotech/
    Instagram: https://www.instagram.com/colabrahq

    The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.


    Trish Jordan: Hollywood and the Percy Schmeiser Story Jan 29, 2022
    Show notes

    The story of Percy Schmeiser is a well known tale of big biotech against the little farmer from rural Saskatchewan. Schmeiser grew canola, and his outstanding harvests were due to herbicide tolerant seeds that he grew himself from materials obtained from means other than purchase. This violation of patent rights became the fodder of activist organizations, and a test of how a large company would respond to an unlicensed use of their technology. Schmeiser became the darling of anti-GMO activists, and he became the figurehead of a conversation about technology, patents, farmers’ rights, and seed sovereignty. This week’s podcast analyzes the film Percy vs. Goliath, a film that attempts to tell Schmeiser’s story. But what was accurate and what was fictionalized in the film? I spoke with Trish Jordan, who at the time was a communications lead at the Monsanto Corporation and followed the story very closely. She had a front-row seat for the legal proceedings and provides her analysis of the film’s veracity.

    Follow Trish on Twitter: @AggieCoolChick
    IMDB page for Percy vs. Goliath

    # COLABRA
    Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

    # TALKING BIOTECH
    Twitter: https://twitter.com/talkingbiotech
    Website: https://www.colabra.app/podcasts/talking-biotech/
    Instagram: https://www.instagram.com/colabrahq

    The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.


    Zack Johnson: The Importance of Telling Ag’s Story Jan 22, 2022
    Show notes

    One of the criticisms of farmers is that they fail to engage the public to show what they do. It is understandable, their days are busy, competition is stiff, and farming selects for folks that shun the spotlight. Still it is critical to meet the public where they are, and that is exactly what Zack Johnson does. Zack is best known as Millennial Famer on YouTube. He posts video accounts of his daily work, but also interesting events that happen on his farm and around his area. The videos provide and educational and informative look at what happens on the farm, the technology, the hardships, the successes. In this episode we discuss his entry into public engagement, his motivations, and how being a celebrity farmer has affected his operation.
    Watch Millennial Farmer on YouTube
    Follow Zack on Twitter
    Millennial Farmer Website

    # COLABRA
    Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

    # TALKING BIOTECH
    Twitter: https://twitter.com/talkingbiotech
    Website: https://www.colabra.app/podcasts/talking-biotech/
    Instagram: https://www.instagram.com/colabrahq

    The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.


    Previous 1 16 17 18 19 20 51 Next

    Related Podcasts

    Science Friday

    1

    Science Friday Astronomy
    The Naked Scientists Podcast

    2

    The Naked Scientists Podcast Life Sciences
    Stuff To Blow Your Mind

    3

    Stuff To Blow Your Mind Life Sciences
    Stuff To Blow Your Mind

    4

    Stuff To Blow Your Mind Life Sciences
    Brain Science with Ginger Campbell, MD: Neuroscience for Everyone

    5

    Brain Science with Ginger Campbell, MD: Neuroscience for Everyone Health & Fitness
    All In The Mind

    6

    All In The Mind Government & Organizations
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights